TCMD · Tactile Systems Technology Inc
$24.20
+0.49 (+2.07%)
At close · Aug 14
Market Cap
$548.19M
Shares
22.65M
Tactile Systems Technology Inc Earnings Call Transcripts
Every quarterly earnings call for Tactile Systems Technology Inc (TCMD) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲24.3%
$65.26M
−$2.28M
'22 Q3
22-11-07
▲19.7%
$73.90M
$4.62M
'22 Q4
23-02-21
▲22.7%
$58.85M
−$1.89M
'23 Q1
23-05-08
▲14.6%
$68.34M
−$100,000
'23 Q2
23-08-07
▲6.6%
$69.59M
$22.30M
'23 Q3
23-11-06
▲5.1%
$77.65M
$8.20M
'23 Q4
24-02-20
▲3.8%
$61.09M
−$2.21M
'24 Q1
24-05-06
▲7.1%
$73.22M
$4.30M
'24 Q2
24-08-05
▲5%
$73.09M
$5.16M
'24 Q3
24-11-04
▲10.2%
$85.58M
$9.72M
'24 Q4
25-02-18
▲0.3%
$61.27M
−$2.97M
'25 Q1
25-05-05
▲7.8%
$78.91M
$3.22M
'25 Q2
25-08-04
▲17.3%
$85.75M
$8.21M
'25 Q3
25-11-03
▲21%
$103.59M
$10.63M
'25 Q4
26-02-17
▲22.8%
$75.27M
−$1.76M
'26 Q1
26-05-04
LATEST
▲8.6%
$85.70M
$7.79M
'26 Q2
26-08-10
Earnings call
FY26 · Q2
2026-08-10
Q2 2026 Tactile Medical Earnings Conference Call
Revenue
$85.70M
▲ 8.6% YoY Diluted EPS
$0.34
▲ 142.9% YoY Gross margin
76.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-02
William Blair 46th Annual Growth Stock Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-04
Tactile Systems Technology Inc Q1 FY2026 Earnings Call
Confident tone
Prior authorization transition for Medicare PCDs
Lymphedema business growth and NCD tailwind
Lymphotech acquisition integration
Revenue
$75.27M
▲ 22.8% YoY Diluted EPS
$-0.08
Gross margin
76.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-17
Tactile Systems Technology Inc Q4 FY2025 Earnings Call
Confident tone
2026 financial outlook and guidance
Lymphedema business momentum and commercial execution
LymphaTech acquisition
Revenue
$103.59M*
▲ 21% YoY Gross margin
78.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-03
Tactile Systems Technology Inc Q3 FY2025 Earnings Call
Confident tone
Lymphedema business recovery and growth
Airway clearance / AffloVest momentum
Flexitouch clinical evidence and payer engagement
Revenue
$85.75M
▲ 17.3% YoY Diluted EPS
$0.36
▲ 71.4% YoY Gross margin
75.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-04
Tactile Systems Technology Inc Q2 FY2025 Earnings Call
Confident tone
Lymphedema Business Performance
Airway Clearance / AffloVest Growth
CRM Implementation and Workflow Tools
Revenue
$78.91M
▲ 7.8% YoY Diluted EPS
$0.14
▼ 22.2% YoY Gross margin
74.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-05
Tactile Systems Technology Inc Q1 FY2025 Earnings Call
Cautious tone
Full-year guidance revision
Lymphedema sales shortfall
Salesforce CRM implementation
Revenue
$61.27M
▲ 0.3% YoY Diluted EPS
$-0.13
Gross margin
74.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-18
Tactile Systems Technology Inc Q4 FY2024 Earnings Call
Positive tone
Lymphedema business performance
Patient leakage and DME documentation burden
Technology modernization and CRM
Revenue
$85.58M*
▲ 10.2% YoY Gross margin
75.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-04
Tactile Systems Technology Inc Q3 FY2024 Earnings Call
Positive tone
Medicare LCD documentation burden
Lymphedema business performance
Margin expansion and profitability
Revenue
$73.09M
▲ 5% YoY Diluted EPS
$0.21
▼ 77.7% YoY Gross margin
75.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-05
Tactile Systems Technology Inc Q2 FY2024 Earnings Call
Confident tone
Lymphedema Market Opportunity
E-Prescribing / Order Acceleration Tool
Leadership Transition & Strategy Refresh
Revenue
$73.22M
▲ 7.1% YoY Diluted EPS
$0.18
Gross margin
73.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-06
Tactile Systems Technology Inc Q1 FY2024 Earnings Call
Positive tone
Lymphedema revenue growth
Airway clearance / AffloVest
Profitability and cash generation
Revenue
$61.09M
▲ 3.8% YoY Diluted EPS
$-0.09
Gross margin
71.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-20
Tactile Systems Technology Inc Q4 FY2023 Earnings Call
Positive tone
Sales force productivity and expansion
Airway clearance (AffloVest) dynamics
Lymphedema product line growth
Revenue
$77.65M*
▲ 5.1% YoY Gross margin
72.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-06
Tactile Systems Technology Inc Q3 FY2023 Earnings Call
Revenue
$69.59M
▲ 6.6% YoY Diluted EPS
$0.94
Gross margin
70.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-07
Tactile Systems Technology Inc Q2 FY2023 Earnings Call
Revenue
$68.34M
▲ 14.6% YoY Diluted EPS
$0.00
Gross margin
70.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-08
Tactile Systems Technology Inc Q1 FY2023 Earnings Call
Revenue
$58.85M
▲ 22.7% YoY Diluted EPS
$-0.09
Gross margin
70.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-21
Tactile Systems Technology Inc Q4 FY2022 Earnings Call
Revenue
$73.90M*
▲ 19.7% YoY Gross margin
70.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-07
Tactile Systems Technology Inc Q3 FY2022 Earnings Call
Revenue
$65.26M
▲ 24.3% YoY Diluted EPS
$-0.11
Gross margin
71.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-01
Tactile Systems Technology Inc Q2 FY2022 Earnings Call
Revenue
$59.65M
▲ 16.8% YoY Diluted EPS
$-0.23
▼ 428.6% YoY Gross margin
72.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-02
Tactile Systems Technology Inc Q1 FY2022 Earnings Call
Revenue
$47.98M
▲ 12.2% YoY Diluted EPS
$-0.78
Gross margin
70.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-22
Tactile Systems Technology Inc Q4 FY2021 Earnings Call
Revenue
$61.73M*
▲ 4.2% YoY Gross margin
72.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-08
Tactile Systems Technology Inc Q3 FY2021 Earnings Call
Revenue
$52.50M
▲ 6.9% YoY Diluted EPS
$-0.17
▼ 241.7% YoY Gross margin
70.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-02
Tactile Systems Technology Inc Q2 FY2021 Earnings Call
Revenue
$51.06M
▲ 45.4% YoY Diluted EPS
$0.07
Gross margin
70.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-03
Tactile Systems Technology Inc Q1 FY2021 Earnings Call
Revenue
$42.77M
▼ 2.1% YoY Diluted EPS
$-0.12
Gross margin
70.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-23
Tactile Systems Technology Inc Q4 FY2020 Earnings Call
Revenue
$59.24M
▲ 3.8% YoY Diluted EPS
$0.61
▲ 177.3% YoY Gross margin
70.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-02
Tactile Systems Technology Inc Q3 FY2020 Earnings Call
Revenue
$49.09M
▼ 1% YoY Diluted EPS
$0.12
▲ 0% YoY Gross margin
71.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-03
Tactile Systems Technology Inc Q2 FY2020 Earnings Call
Revenue
$35.12M
▼ 22.3% YoY Diluted EPS
$-0.72
▼ 614.3% YoY Gross margin
70.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-04
Tactile Systems Technology Inc Q1 FY2020 Earnings Call
Revenue
$43.67M
▲ 16.1% YoY Diluted EPS
$-0.07
▼ 187.5% YoY Gross margin
71.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Showing 1–27 of 27 earnings calls
Key facts
CIK
1027838
CUSIP
87357P100
13F (30d)
169 filings
167 filers
Visit website
Investor relations